ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "radiography"

  • Abstract Number: 0515 • ACR Convergence 2023

    Dose Adjustment of Tumor Necrosis Factor Inhibitors Does Not Correlated with Radiographic Progression in Patients with Ankylosing Spondylitis

    Bon San Koo1, Seo Young Park2, Ji Hui Shin3, Seunghun lee3, kyung bin Joo3 and Tae-Hwan Kim4, 1Inje University Seoul Paik Hospital, Seoul, South Korea, 2Korea National Open University, Seoul, South Korea, 3Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 4Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea

    Background/Purpose: Among patients with ankylosing spondylitis (AS) treated with tumor necrosis factor (TNF) inhibitors, tapering the dose of TNF inhibitors may be considered for patients…
  • Abstract Number: 0698 • ACR Convergence 2023

    Differentiating Large Vessel Vasculitis from Vasculitis Mimickers in a Real World Setting: Clinical Presentation, Laboratory Tests and Radiographic Findings

    James haigney1, Laura Fandino1 and Vasileios Kyttaris2, 1Beth Israel Deaconess Medical Center, Boston, MA, 2BIDMC, Boston, MA

    Background/Purpose: As the resolution of Computed Tomography Angiography (CTA) has improved, rheumatologists have faced an increased volume of consults to evaluate patients for the presence…
  • Abstract Number: 0842 • ACR Convergence 2023

    Low Rate of Switching from Nr-axSpA to r-axSpA After 10 Years of Follow up in Early Axialspondyloarthritis. Data from DESIR Cohort

    Anna Molto1, Clementina López Medina2, Manouk de Hooge3, Miranda Van Lunteren4, Alexandre Sepriano5, Sofia Ramiro6 and Maxime Dougados7, 1HOPITAL COCHIN AP-HP, Service de Rhumatologie, Paris, France, 2Rheumatology Department, Cochin Hospital; INSERM (U1153): Clinical Epidemiology and Biostatistics, University of Paris; Rheumatology Department, Reina Sofia Hospital, Cordoba / IMIBIC / University of Cordoba, Cordoba, Spain, 3Ghent University Hospital, Hesperange, Luxembourg, 4Leiden University Medical Center, Department of Rheumatology, Leiden, Netherlands, 5Leiden University Medical Centre, Portela Loures, Portugal, 6Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 7Rheumatology Department, Cochin Hospital; INSERM (U1153): Clinical Epidemiology and Biostatistics, University of Paris, Paris, France

    Background/Purpose: The objective of this analysis was to evaluate the proportion of patients switching from non-radiographic axSpA (nr-axSpA) toradiographic axSpA (r-axSpA) after 10 years of…
  • Abstract Number: 0860 • ACR Convergence 2023

    Vagus Nerve Stimulation Enhances Bone Morphology in a Rodent Model of Central Nervous System Inflammation

    Chandramohan Natarajan1, Julia Lucchino1, David Chenoff2 and Yaakov Levine1, 1SetPoint Medical, Valencia, CA, 2SetPoint Medical, Sausalito, CA

    Background/Purpose: Electrical stimulation of the vagus nerve activates the inflammatory reflex to inhibit cytokines and decrease clinical signs and symptoms of chronic inflammatory disease such…
  • Abstract Number: 1198 • ACR Convergence 2023

    Bicycling Is Not Associated with New Knee Pain or Disease Progression over 48 Months in Those with Knee Osteoarthritis: Data from the Osteoarthritis Initiative

    Colin McLaughlin1, Grace Lo1, Jeffrey Driban2, Timothy McAlindon3, Andrea Kriska4, Bonnie Rockette-Wagner4, Marc Hochberg5, Michael Nevitt6, Kent Kwoh7 and Charles Eaton8, 1Baylor College of Medicine, Houston, TX, 2Tufts Medical Center, Westborough, MA, 3Tufts Medical Center, Arlington, MA, 4University of Pittsburgh, Pittsburgh, PA, 5University of Maryland School of Medicine, Baltimore, MD, 6University of California San Francisco, Orinda, CA, 7University of Arizona, Tucson, AZ, 8Brown University, Pawtucket, RI

    Background/Purpose: Bicycling is viewed as a non-weight bearing exercise and is often recommended as a preferred exercise for those with knee osteoarthritis (OA).However, there is…
  • Abstract Number: 1273 • ACR Convergence 2023

    Long-term Follow-up of Treated-to-target RA and UA: Results of the BeSt and IMPROVED Studies

    Sascha Heckert1, Johanna Maria Maassen1, Isabell Nevins2, F. Fodili3, Margreet Steup-Beekman4, Thomas Huizinga1, Sytske Anne Bergstra1 and CF Allaart1, 1Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center, Amsterdam, Netherlands, 3Stichting ReumaZorg ZWN, Roosendaal, Netherlands, 4Leiden University Medical Center, Den Haag, Netherlands

    Background/Purpose: In 2 trials with an original follow-up of 5-10 years, patients with early arthritis were treated to target, resulting in low disease activity or…
  • Abstract Number: 1389 • ACR Convergence 2023

    Low Spinal Radiographic Progression After a Mean of 15 Years of Follow-up in a Cohort of Patients with Axial Spondyloarthritis

    raquel granados1, Santiago Dans-Caballero1, Lourdes Ladehesa Pineda2, María Ángeles Puche Larrubia3, Desiree Ruiz Vilchez4, Maria del Carmen Abalos-Aguilera4, Alejandro Escudero-Contreras5, Eduardo Collantes Estévez6 and Clementina López Medina7, 1Rheumatology Department, Reina Sofia University Hospital, Cordoba/Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, Spain, 2Rheumatology Department Reina Sofia Universitary Hospital, Cordoba, Spain, 3Department of Rheumatology, Reina Sofia University Hospital, Cordoba, Spain, 4Rheumatology Department, Reina Sofia University Hospital/Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Córdoba, Spain, 5Rheumatology Department, Reina Sofia University Hospital, Cordoba/Maimonides Biomedical Research Institute of Cordoba (IMIBIC)/University of Cordoba, Córdoba, Spain, 6Maimonides Biomedical Research Institute of Cordoba (IMIBIC)/University of Cordoba, Cordoba, Spain, 7Rheumatology Department, Cochin Hospital; INSERM (U1153): Clinical Epidemiology and Biostatistics, University of Paris; Rheumatology Department, Reina Sofia Hospital, Cordoba / IMIBIC / University of Cordoba, Cordoba, Spain

    Background/Purpose: Axial spondyloarthritis (axSpA) is characterized by progressive structural damage on the sacroiliac joints and/or the spine. Conventional radiology allows to assess radiology through available…
  • Abstract Number: 1401 • ACR Convergence 2023

    The Association of 3VAS/4VAS and DAPSA with Radiographic Progression in Early PsA

    Gonul Hazal Koc1, Marc r. Kok2, Jolanda J. Luime1, ilja Tchetverikov3, William R Tillett4, Fazira R. Kasiem1, Lindy A. Korswagen5, J. Bijsterbosch6, Yvonne P. M. Goekoop-Ruiterman7, Maikel van oosterhout8, P. Baudoin9, Petra Kok10, radboud J.e.m. Dolhain11 and marijn vis1, 1Erasmus Medical Center, Rotterdam, Netherlands, 2Maasstad Hospital, Rotterdam, Netherlands, 3Albert Sweitzer Hospital, Dordrecht, Netherlands, 4Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, 5Franciscus Gasthuis & Vlietland, Rotterdam, Netherlands, 6Amphia Hospital, Rotterdam, Netherlands, 7Haga Ziekenhuis, The Hague, Netherlands, 8Groene Hart Ziekenhuis, Gouda, Netherlands, 9Reumazorg Zuid West Nederland, Roosendaal, Netherlands, 10Reinier de Graaf Gasthuis, Delft, Netherlands, 11Rheumatology, Erasmus MC, Rotterdam, Netherlands

    Background/Purpose: A feasible, widely accepted, comprehensive disease activity measure is needed for daily use in psoriatic arthritis (PsA). Current measures are either complex (Psoriatic Arthritis…
  • Abstract Number: 1868 • ACR Convergence 2023

    Long-term Efficacy of a 2-year MRI Treat-to-target Strategy on Radiographic Joint Damage Progression in Rheumatoid Arthritis Patients in Clinical Remission – Five Year Follow-up of the IMAGINE-RA Randomized Clinical Trial

    Signe Møller-Bisgaard1, Kim Hørslev-Petersen2, Lykke Ørnbjerg1, Bo Ejbjerg3, Merete L Hetland1, Jakob Moeller4, Robin Christensen5, Sabrina Mai Nielsen6, Daniel Glinatsi7, Mikael Boesen8, Kristian Stengaard-Pedersen9, Ole Rintek Madsen10, Bente Jensen11, Jan Alexander Villadsen2, Ellen-Margrethe Hauge9, Oliver Hendricks2, Hanne Merete Lindegaard12, Niels Steen Krogh13, Anne Grethe Jurik9, Henrik Thomsen4 and Mikkel Østergaard14, 1Copenhagen Center for Arthritis Research, Rigshospitalet, Copenhagen, Denmark, 2Danish Hospital for Rheumatic Diseases, Sønderborg, Denmark, 3Slagelse Hospital, Slagelse, Denmark, 4Herlev-Gentofte Hospital, Herlev, Denmark, 5Musculoskeletal Statistics Unit, The Parker Institute, Copenhagen, Denmark, 6The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark, 7Copenhagen Center for Arthritis Research, Rigshospitalet, Copenhagen, Sweden, 8Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital, Naerum, Denmark, 9Aarhus University Hospital, Aarhus, Denmark, 10Herlev-Gentofte Hospital, Gentofte, Denmark, 11Bispebjerg-Frederiksberg Hospital, Frederiksberg, Denmark, 12Odense Hospital, Odense, Denmark, 13ZiteLab ApS, Frederiksberg, Denmark, 14Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet; University of Copenhagen, Copenhagen, Denmark

    Background/Purpose: Radiographic joint damage progresses in 20-30% of rheumatoid arthritis (RA) patients despite fulfilling clinical remission criteria (1). Osteitis assessed on MRI is a well…
  • Abstract Number: 1881 • ACR Convergence 2023

    Deep Learning Approaches to Rheumatoid Arthritis Severity Prognosis

    Zhong-Yuan Lai1, Aditya Varna Iyer2, Isaac Zachary To1, Ivano Lodato1, Simran Hiranandani1, Tommy LAM3, Ho So4 and Lai-Shan Tam5, 1Allos AI, London, United Kingdom, 2Allos AI, University of Oxford, Oxford, United Kingdom, 3Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, Hong Kong, 4Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 5The Chinese University of Hong Kong, New Territories, China

    Background/Purpose: Rheumatoid arthritis (RA) is the most common form of inflammatory arthritis affecting a large sector of the global population. The disease is associated with…
  • Abstract Number: 098 • 2023 Pediatric Rheumatology Symposium

    Characterization of Pulmonary Nodules in Juvenile-onset Systemic Sclerosis: A Single Center Case-Series

    Jonathan Li1, Franziska Rosser1, Sameh Tadros1 and Kathryn Torok2, 1UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Given the high prevalence of intestinal lung disease (ILD) in systemic sclerosis (SSc) and the low sensitivity of pulmonary function testing for diagnosing ILD,…
  • Abstract Number: 1971 • ACR Convergence 2022

    Cumulative Joint Inflammation Is Associated with Local Joint Damage Progression in Rheumatoid Arthritis Despite Long-Term Targeted Treatment

    Sascha Heckert1, Sytske Anne Bergstra2, Yvonne Goekoop-Ruiterman3, Melek Guler-Yuksel4, Willem Lems5, Xanthe Matthijssen6, Maikel Van Oosterhout7, Tom Huizinga6 and CF Allaart6, 1Leiden University Medical Centre, Leiden, Netherlands, 2LUMC, Leiden, Netherlands, 3HagaZiekenhuis, The Hague, Netherlands, 4Maasstad ziekenhuis, Rotterdam, Netherlands, 5Amsterdam University Medical Centers, Amsterdam, Netherlands, 6Leiden University Medical Center, Leiden, Netherlands, 7Groene Hart Ziekenhuis, Gouda, Netherlands

    Background/Purpose: In Rheumatoid Arthritis (RA), both systemic and local disease activity have been shown to be associated with joint damage progression. Earlier we showed that…
  • Abstract Number: 2011 • ACR Convergence 2022

    More Meticulously Following Treat-to-target in RA Does Not Lead to Less Radiographic Progression: A Longitudinal Analysis in BIODAM

    Sofia Ramiro1, Robert Landewé2, Désirée van der Heijde3, Alexandre Sepriano4, Oliver FitzGerald5, Mikkel Østergaard6, Joanne Homik7, Ori Elkayam8, Carter Thorne9, Maggie Larche10, Gianfranco Ferraccioli11, Marina Backhaus12, Gilles Boire13, Bernard Combe14, Thierry Schaeverbeke15, Alain Saraux16, Maxime Dougados17, Maurizio Rossini18, Marcello Govoni19, Luigi Sinigaglia20, Alain Cantagrel21, CF Allaart1, Cheryl Barnabe22, Clifton O. Bingham III23, Dirkjan van Schaardenburg24, HIlde Hammer25, Rana Dadashova26, Edna Hutchings26, Joel Paschke26 and Walter P Maksymowych27, 1Leiden University Medical Center, Leiden, Netherlands, 2Amsterdam University Medical Center, Meerssen, Netherlands, 3Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, Leiden, Netherlands, 4Leiden University Medical Centre, Portela Loures, Portugal, 5Conway Institute, University College Dublin, Dublin, Ireland, 6Rigshospitalet, University of Copenhagen, Glostrup, Denmark, 7Division of Rheumatology, University of Alberta, Edmonton, AB, Canada, 8Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 9Southlake Regional Health Centre, Newmarket, ON, Canada, 10McMaster University, Hamilton, ON, Canada, 11Catholic University of the Sacred Heart, Rome, Roma, Italy, 12Park-Klinik Weissensee Academic Hospital of the Charité, Berlin, Germany, 13Universite de Sherbrooke, Sherbrooke, QC, Canada, 14CHU Montpellier and Montpellier University, Monpellier, France, 15FHU ACRONIM, University Hospital of Bordeaux, University of Bordeaux, Bordeaux, France, 16CHU Brest, Brest, France, 17Department of Rheumatology, Hôpital Cochin, Paris, France, Paris, France, 18Rheumatology Unit, Department of Medicine, University of Verona, Verona, Italy, 19S. Anna Hospital and University of Ferrara, Ferrara, Italy, 20Gaetano Pini Institute, Milano, Italy, 21CHU Toulouse, Paul Sabatier University, Toulouse, France, 22University of Calgary, Calgary, AB, Canada, 23Johns Hopkins University, Baltimore, MD, 24Amsterdam UMC, Amsterdam, Netherlands, 25Diakonhjemmet Hospital, Oslo, Oslo, Norway, 26CARE Arthritis LTD, Edmonton, AB, Canada, 27Department of Medicine, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: A Treat-to-Target approach (T2T) is broadly considered to lead to better clinical outcomes and recommended in patients with RA. However, very few studies have…
  • Abstract Number: 0097 • ACR Convergence 2022

    Sex and Race/ethnicity Differences in Knee Symptoms, Function, and Radiographic Features: Preliminary Descriptive Data from the Johnston County Health Study

    Luis Palomino1, Carolina Alvarez2, Todd Schwartz3, Yvonne Golightly4 and Amanda Nelson2, 1University of North Carolina Chapel hill, Chapel Hill, NC, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, 3University of North Carolina-Chapel Hill, Chapel Hill, NC, 4University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Osteoarthritis (OA) is the most common form of joint disorder worldwide. Differences in pain, function, and radiographic features in ethnic groups, specifically Hispanics, are…
  • Abstract Number: 1008 • ACR Convergence 2022

    Endothelial Dysfunction in Axial Spondyloarthritis and Its Association with Clinical Disease Characteristics

    lourdes Ladehesa-Pineda1, Clementina Lopez-Medina2, Maria Angeles Puche Larrubia3, Raquel Granados4 and Eduardo Collantes5, 1Reina Sofia University Hospital/Rheumatology Department/Maimonides Institute for Biomedical Research (IMIBIC), Cordoba, Spain, 2Reina Sofia University Hospital, Rheumatology Department, Jaén, Spain, 3Reina Sofia University Hospital/Rheumatology Department/Maimonides Institute for Biomedical Research (IMIBIC), Granada, Spain, 4Reina Sofia University Hospital/Rheumatology Department/Maimonides Institute for Biomedical Research (IMIBIC), Córdoba, Spain, 5IMIBIC/University of Cordoba/Reina Sofia Hospital, Cordoba, Spain

    Background/Purpose: It has been described an increased presence of cardiovascular risk factors and subclinical atherosclerosis in patients with axial spondyloarthritis (axSpA). Several studies have shown…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology